Skip to main content
Top

16-05-2024 | Osteoporosis | Original Article

Impact of osteoporotic risk in men undergoing transcatheter aortic valve replacement: a report from the LAPLACE-TAVI registry

Authors: Takashi Funaki, Mike Saji, Ryosuke Higuchi, Itaru Takamisawa, Mamoru Nanasato, Harutoshi Tamura, Kei Sato, Hiroaki Yokoyama, Shinichiro Doi, Shinya Okazaki, Takayuki Onishi, Tetsuya Tobaru, Shuichiro Takanashi, Takanori Ikeda, Hiroaki Kitaoka, Mitsuaki Isobe

Published in: Cardiovascular Intervention and Therapeutics

Login to get access

Abstract

Low body weight and advanced age are among the best predictors of osteoporosis. Osteoporosis Self-Assessment Tool (OST) values are calculated by a simple formula [(body weight in kilograms – age in years) × 0.2] to identify patients at increased risk of osteoporosis. In our recent single-center study, we demonstrated an association between OST and poor outcomes in postmenopausal women after transcatheter aortic valve replacement (TAVR). We aimed to investigate the impact of osteoporotic risk in men with aortic stenosis who underwent TAVR in a large cohort. In this multi-center study, 1,339 men who underwent TAVR between April 2010 and July 2023 were retrospectively analyzed. Women were excluded from the present study. All patients were deemed appropriate for TAVR after a review by a multidisciplinary team. Baseline characteristics of patients were compared by dividing patients into three tertiles, based on the OST value: ≤ − 6.16, − 6.16 to − 4.14, and − 4.14 < for tertiles 1, 2, and 3, respectively. Primary endpoint was all-cause mortality after TAVR. Tertile 1 (patients with the lowest OST values) included older patients with smaller body mass index, lower hemoglobin and albumin levels. In addition, they had greater clinical frailty scale, slower 5-meter walk test, weaker hand grip strength, and more cognitive impairment, indicating increased frailty. They were more severely symptomatic, with lower ejection fractions, smaller aortic valve areas, and more tricuspid regurgitation than were patients in the other two groups. Multivariate analysis revealed that OST tertiles 3 was associated with decreased risk of all-cause mortality (hazard ratio, 0.66; 95% confidence interval, 0.48–0.90), compared with OST tertile 1 as a reference. For OST tertiles 1, 2, and 3, the estimated 1-year survival rates of all-cause mortality post-TAVR were 83.6% ± 1.9%, 91.1% ± 1.4%, and 93.1% ± 1.3%, respectively, (log-rank, p < 0.001). In conclusions, in men as same as women, osteoporotic risk assessed by OST values was overlapped with increased frailty. The simple OST formula was useful for predicting all-cause mortality in patients undergoing TAVR in large registry datasets.

Graphical Abstract

Literature
1.
go back to reference Peck WA. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med. 1993;94:646–50.CrossRef Peck WA. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med. 1993;94:646–50.CrossRef
2.
go back to reference Siris ES, Miller PD, Barrett-Connor E, et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the national osteoporosis risk assessment. JAMA. 2001;286:2815–22.CrossRefPubMed Siris ES, Miller PD, Barrett-Connor E, et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the national osteoporosis risk assessment. JAMA. 2001;286:2815–22.CrossRefPubMed
3.
go back to reference Koh LKH, Sedrine WB, Torralba TP, et al. A simple tool to identify Asian women at increased risk of osteoporosis. Osteoporos Int. 2001;12:699–705.CrossRefPubMed Koh LKH, Sedrine WB, Torralba TP, et al. A simple tool to identify Asian women at increased risk of osteoporosis. Osteoporos Int. 2001;12:699–705.CrossRefPubMed
4.
go back to reference Dargent-Molina P, Poitiers F, Breart G, EPIDOS Group. In elderly women weight is the best predictor of a very low bone mineral density: evidence from the EPIDOS study. Osteoporos Int. 2000;11:881–8.CrossRefPubMed Dargent-Molina P, Poitiers F, Breart G, EPIDOS Group. In elderly women weight is the best predictor of a very low bone mineral density: evidence from the EPIDOS study. Osteoporos Int. 2000;11:881–8.CrossRefPubMed
5.
go back to reference Chang AJ, Ying Q, Chen XN, Wang WM, Chen N. Evaluation of three risk assessment tools in discriminating fracture status among Chinese patients undergoing hemodialysis. Osteoporos Int. 2016;27:3599–606.CrossRefPubMed Chang AJ, Ying Q, Chen XN, Wang WM, Chen N. Evaluation of three risk assessment tools in discriminating fracture status among Chinese patients undergoing hemodialysis. Osteoporos Int. 2016;27:3599–606.CrossRefPubMed
6.
go back to reference Logan S, Thu WPP, Lay WK, Wang LY, Cauley JA, Yong EL. Chronic joint pain and handgrip strength correlates with osteoporosis in mid-life women: a Singaporean cohort. Osteoporos Int. 2017;28:2633–43.CrossRefPubMed Logan S, Thu WPP, Lay WK, Wang LY, Cauley JA, Yong EL. Chronic joint pain and handgrip strength correlates with osteoporosis in mid-life women: a Singaporean cohort. Osteoporos Int. 2017;28:2633–43.CrossRefPubMed
7.
go back to reference Subramaniam S, Chan CY, Soelaiman IN, et al. The performance of osteoporosis self-assessment tool for Asians (OSTA) in identifying the risk of osteoporosis among Malaysian population aged 40 years and above. Arch Osteoporos. 2019;14:117.CrossRefPubMed Subramaniam S, Chan CY, Soelaiman IN, et al. The performance of osteoporosis self-assessment tool for Asians (OSTA) in identifying the risk of osteoporosis among Malaysian population aged 40 years and above. Arch Osteoporos. 2019;14:117.CrossRefPubMed
8.
go back to reference Leon MB, Smith CR, Mack M, PARTNER Trial Investigators, et al. Transcatheter aortic valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–607.CrossRefPubMed Leon MB, Smith CR, Mack M, PARTNER Trial Investigators, et al. Transcatheter aortic valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–607.CrossRefPubMed
9.
go back to reference Saji M, Higuchi R, Izumi Y, et al. Prevalence and impact of fracture on postmenopausal women with aortic stenosis who underwent transcatheter aortic valve replacement. Cardiovasc Interv Ther. 2022;37:543–8.CrossRefPubMed Saji M, Higuchi R, Izumi Y, et al. Prevalence and impact of fracture on postmenopausal women with aortic stenosis who underwent transcatheter aortic valve replacement. Cardiovasc Interv Ther. 2022;37:543–8.CrossRefPubMed
11.
go back to reference Chieffo A, Petronio AS, Mehilli J, et al. Acute and 30-day outcomes in women after TAVR: results from the WIN-TAVI (women’s INternational transcatheter aortic valve implantation) real-world registry. JACC Cardiovasc Interv. 2016;9:1589–600.CrossRefPubMed Chieffo A, Petronio AS, Mehilli J, et al. Acute and 30-day outcomes in women after TAVR: results from the WIN-TAVI (women’s INternational transcatheter aortic valve implantation) real-world registry. JACC Cardiovasc Interv. 2016;9:1589–600.CrossRefPubMed
12.
go back to reference US Preventive Services Task Force, Curry SJ, Krist AH, Owens DK, et al. Screening for osteoporosis to prevent fractures: US preventive services task force recommendation statement. JAMA. 2018;319:2521–31.CrossRef US Preventive Services Task Force, Curry SJ, Krist AH, Owens DK, et al. Screening for osteoporosis to prevent fractures: US preventive services task force recommendation statement. JAMA. 2018;319:2521–31.CrossRef
13.
go back to reference Yokoyama H, Tobaru T, Muto Y, et al. Long-term outcomes in Japanese nonagenarians undergoing transcatheter aortic valve implantation: a multi-center analysis. Clin Cardiol. 2019;42:605–11.CrossRefPubMedPubMedCentral Yokoyama H, Tobaru T, Muto Y, et al. Long-term outcomes in Japanese nonagenarians undergoing transcatheter aortic valve implantation: a multi-center analysis. Clin Cardiol. 2019;42:605–11.CrossRefPubMedPubMedCentral
14.
go back to reference Nishida K, Saji M, Higuchi R, et al. Predictors for all-cause mortality in men after transcatheter aortic valve replacement: a report from the LAPLACE-TAVI Registry. Int J Cardiol Heart Vasc. 2023;48:101257.PubMedPubMedCentral Nishida K, Saji M, Higuchi R, et al. Predictors for all-cause mortality in men after transcatheter aortic valve replacement: a report from the LAPLACE-TAVI Registry. Int J Cardiol Heart Vasc. 2023;48:101257.PubMedPubMedCentral
15.
go back to reference Zoghbi WA, Adams D, Bonow RO, et al. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American society of echocardiography developed in collaboration with the society for cardiovascular magnetic resonance. J Am Soc Echocardiogr. 2017;30:303–71.CrossRefPubMed Zoghbi WA, Adams D, Bonow RO, et al. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American society of echocardiography developed in collaboration with the society for cardiovascular magnetic resonance. J Am Soc Echocardiogr. 2017;30:303–71.CrossRefPubMed
16.
go back to reference Shimura T, Yamamoto M, Kano S, et al. Impact of the clinical frailty scale on outcomes after transcatheter aortic valve replacement. Circulation. 2017;135:2013–24.CrossRefPubMed Shimura T, Yamamoto M, Kano S, et al. Impact of the clinical frailty scale on outcomes after transcatheter aortic valve replacement. Circulation. 2017;135:2013–24.CrossRefPubMed
17.
go back to reference Saji M, Tobaru T, Higuchi R, et al. Cognitive assessment using the revised Hasegawa’s dementia scale to determine the mid-term outcomes following transcatheter aortic valve replacement. J Cardiol. 2019;74:206–11.CrossRefPubMed Saji M, Tobaru T, Higuchi R, et al. Cognitive assessment using the revised Hasegawa’s dementia scale to determine the mid-term outcomes following transcatheter aortic valve replacement. J Cardiol. 2019;74:206–11.CrossRefPubMed
18.
go back to reference Fried LP, Tangen CM, Walston J, Cardiovascular Health Study Collaborative Research Group, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146–56.CrossRefPubMed Fried LP, Tangen CM, Walston J, Cardiovascular Health Study Collaborative Research Group, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146–56.CrossRefPubMed
19.
go back to reference Huemer MT, Kluttig A, Fischer B, et al. Grip strength values and cut-off points based on over 200,000 adults of the German National Cohort—a comparison to the EWGSOP2 cut-off points. Age Ageing. 2023;2023(52):afac324.CrossRef Huemer MT, Kluttig A, Fischer B, et al. Grip strength values and cut-off points based on over 200,000 adults of the German National Cohort—a comparison to the EWGSOP2 cut-off points. Age Ageing. 2023;2023(52):afac324.CrossRef
20.
go back to reference Prasad D, Nguyen MH. Chronic hepatitis, osteoporosis, and men: under-recognised and underdiagnosed. Lancet Diabetes Endocrinol. 2021;9:141.CrossRefPubMed Prasad D, Nguyen MH. Chronic hepatitis, osteoporosis, and men: under-recognised and underdiagnosed. Lancet Diabetes Endocrinol. 2021;9:141.CrossRefPubMed
21.
22.
go back to reference Gielen E, Dupont J, Dejaeger M, Laurent MR. Sarcopenia, osteoporosis and frailty. Metabolism. 2023;145:155638.CrossRefPubMed Gielen E, Dupont J, Dejaeger M, Laurent MR. Sarcopenia, osteoporosis and frailty. Metabolism. 2023;145:155638.CrossRefPubMed
24.
go back to reference Sergi G, Veronese N, Fontana L, et al. Pre-frailty and risk of cardiovascular disease in elderly men and women: the Pro.V.A. J Am Coll Cardiol. 2015;65:976–83.CrossRefPubMed Sergi G, Veronese N, Fontana L, et al. Pre-frailty and risk of cardiovascular disease in elderly men and women: the Pro.V.A. J Am Coll Cardiol. 2015;65:976–83.CrossRefPubMed
Metadata
Title
Impact of osteoporotic risk in men undergoing transcatheter aortic valve replacement: a report from the LAPLACE-TAVI registry
Authors
Takashi Funaki
Mike Saji
Ryosuke Higuchi
Itaru Takamisawa
Mamoru Nanasato
Harutoshi Tamura
Kei Sato
Hiroaki Yokoyama
Shinichiro Doi
Shinya Okazaki
Takayuki Onishi
Tetsuya Tobaru
Shuichiro Takanashi
Takanori Ikeda
Hiroaki Kitaoka
Mitsuaki Isobe
Publication date
16-05-2024
Publisher
Springer Nature Singapore
Published in
Cardiovascular Intervention and Therapeutics
Print ISSN: 1868-4300
Electronic ISSN: 1868-4297
DOI
https://doi.org/10.1007/s12928-024-01011-7

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

Keynote webinar | Spotlight on medication adherence

  • Webinar | 27-06-2024 | 18:00 (CEST)

Medication non-adherence is a major barrier to effective healthcare delivery; half of all patients do not follow their doctor’s recommendations or treatment plan.

Our experts explain the fundamentals with a practical discussion of how to manage non-adherence in two common scenarios: hypertension and asthma control.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Watch now